Factors for PBPC collection efficiency and collection predictors (Q35958579)

11 August 2017

1 reference

title

Factors for PBPC collection efficiency and collection predictors (English)

1 reference

11 August 2017

Kazuma Ikeda

1

1 reference

PubMed ID

15556472

11 August 2017

Teruhiko Kozuka

series ordinal

2

1 reference

PubMed ID

15556472

11 August 2017

Mine Harada

series ordinal

3

1 reference

11 August 2017

1 December 2004

1 reference

Transfusion and Apheresis Science

11 August 2017

1 reference

11 August 2017

31

1 reference

11 August 2017

3

1 reference

11 August 2017

245-259

1 reference

High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Peripheral blood stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Circulating CD34+ hematopoietic progenitors in the harvesting peripheral blood stem cells; enhancement by recombinant human granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Kinetics of circulating haematopoietic progenitors during chemotherapy-induced mobilization with or without granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Granulocyte colony-stimulating factor (G-CSF)-induced mobilization of circulating haemopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Proliferative effects of several hematopoietic growth factors on acute myelogenous leukemia cells and correlation with treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Response of leukemic cells to the sequential combination of gm‐csf and g‐csf

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated leukapheresis system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Influence of preapheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Granulocyte colony-stimulating factor-induced mobilization of peripheral blood stem cells for autologous and allogeneic transplantation. Fukuoka Bone Marrow Transplantation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Assessment of rapid remobilization intervals with G-CSF and SCF in murine and rhesus macaque models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Determination of peripheral blood stem cells by the Sysmex SE-9500.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.09.008

10.1016/J.TRANSCI.2004.09.008

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15556472